Mirati Therapeutics Inc. (MRTX)
NASDAQ: MRTX
· Real-Time Price · USD
58.70
-0.10 (-0.17%)
At close: Jan 22, 2024, 10:00 PM
Mirati Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -161.9M | -176.91M | -184.59M | -202.47M | -173.56M | -176.44M | -188.39M | -199.62M | -80.05M | -166.43M | -135.68M |
Depreciation & Amortization | 1.11M | 1.11M | 1.07M | 891K | 716K | 693K | 629K | 562K | 514K | 411K | 294K |
Stock-Based Compensation | 44.55M | 39.4M | 46.96M | 61.61M | 42.99M | 38.68M | 42.91M | 33.88M | 26.93M | 27.97M | 24.72M |
Other Working Capital | -6.96M | 20.74M | 41.01M | 25.64M | n/a | n/a | 298K | 2.04M | n/a | n/a | -9.08M |
Other Non-Cash Items | 117.35M | 137.51M | -5.06M | -5.71M | -10.34M | 1.28M | 6.06M | 4.23M | -1.03M | 3.95M | 4.95M |
Deferred Income Tax | -122.23M | -144.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -22.6M | 11.65M | -48.58M | 16.89M | 2.38M | -7.7M | -21.68M | 22.96M | 6.6M | 40.73M | -4.71M |
Operating Cash Flow | -143.71M | -131.4M | -190.18M | -128.8M | -137.81M | -143.49M | -160.47M | -137.99M | -47.03M | -93.37M | -110.42M |
Capital Expenditures | -36K | -722K | -269K | -810K | -1.24M | -1.66M | -1.14M | -2.65M | -2.01M | -4.03M | -1.11M |
Cash Acquisitions | 62.16M | -16.25M | -195.42M | -60.11M | -15.19M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -341.66M | -237.05M | -126.71M | -237.33M | -377.9M | -128.93M | -212.54M | -363.59M | -293.25M | -144.23M | -621.66M |
Sales Maturities Of Investments | 279.5M | 253.3M | 322.13M | 297.44M | 393.08M | 233.59M | 263.24M | 195.4M | 295.96M | 185.02M | 167.24M |
Other Investing Acitivies | -62.16M | 16.25M | 195.42M | 60.11M | 15.19M | 104.67M | 50.7M | -168.19M | 2.71M | 40.79M | -454.42M |
Investing Cash Flow | -62.19M | 15.53M | 195.15M | 59.3M | 13.95M | 103.01M | 49.55M | -170.84M | 704K | 36.76M | -455.53M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 334.7M | 3.84M | 1.73M | 5.92M | 157.1M | 1.39M | 2.53M | 479.28M | 8.23M | 7.82M | 9.88M |
Financial Cash Flow | 334.7M | 3.84M | 1.73M | 5.92M | 157.1M | 1.39M | 2.53M | 479.28M | 8.23M | 7.82M | 9.88M |
Net Cash Flow | 128.85M | -112.06M | 6.67M | -63.58M | 33.24M | -39.09M | -108.39M | 170.46M | -38.1M | -48.78M | -556.06M |
Free Cash Flow | -143.75M | -132.12M | -190.45M | -129.61M | -139.05M | -145.15M | -161.61M | -140.63M | -49.04M | -97.4M | -111.52M |